T1	Participants 84 146	chemo-naïve patients with advanced non-small cell lung cancer
T2	Participants 288 339	in chemo-naïve non-small cell lung cancer patients
T3	Participants 341 456	METHODS Patients with chemo-naïve stage IIIB/IV non-small cell lung cancer were randomized into two treatment arms
T4	Participants 653 710	RESULTS A total of 80 patients were entered in this trial
